
UTEC, a venture investment firm headquartered in Chiyoda, Japan. In addition, organization was launched in 2004 and targets investments in formative-stage companies in Japan, the US, Europe, SE Asia and India. UTEC has funded upwards of 100 formative-stage companies, presenting value-adds such as T cell receptor (TCR)/B cell receptor (BCR) repertoire analysis that is based on unbiased gene annotation. Through targeted capital deployment, the fund plays an active role in the startup ecosystem.
- Cheque size
- $1M – $4M
- Industries
- Operating in
- How they invest
- Not specified
- Technologies
- Not specified

